This is systematic fraud, and anyone trying those antibodies with falsified data will waste money and time. A lot of papers have been retracted for similar issues. Thermo Fisher is a major worldwide supplier of antibodies, so this has quite a big practical impact.

1. Obviously unethical and fraudulent behavior.

2. It should be determined whether the fraud was just the display image (imagine a sales manager making a bad call when images are not available) or involved the underlying research (more systemic and worrying).

3. It would be interesting to examine occurrence of faked images along with apparent unreliability/irreproducibility of research that has used those products.